The global terminal sterilization services market is experiencing significant growth as healthcare providers, pharmaceutical manufacturers, and medical device companies place greater emphasis on infection prevention, patient safety, regulatory compliance, and validated sterilization processes. Terminal sterilization is particularly important because products can be sterilized in their final container or packaging, helping achieve a high level of sterility assurance before they reach patients. Increasing healthcare-associated infections (HAIs), rising surgical volumes, and growing demand for sterile medical devices are strengthening the need for reliable sterilization services worldwide. 

Market Size and Growth Outlook

According to Grand View Research, the terminal sterilization services market is expanding steadily over the forecast period.

• Market size in 2025: USD 14.0 billion

• Estimated market size in 2026: USD 15.0 billion

• Projected market size by 2033: USD 25.5 billion

• CAGR from 2026 to 2033: 7.8%

The growth reflects increasing demand for validated sterilization across hospitals, pharmaceutical facilities, medical device manufacturing, and other healthcare environments. North America remained the leading regional market, accounting for 33.8% of global revenue in 2025. 

Download a free sample copy of the Terminal Sterilization Services Market report to understand detailed coverage and inclusions in the final report

Key Market Segments

Product Landscape

Equipment represents an important part of the terminal sterilization ecosystem. The equipment segment accounted for 41.0% of revenue in 2025, according to Grand View Research. Sterilization equipment includes steam autoclaves, ethylene oxide systems, hydrogen peroxide sterilizers, and other technologies used to process medical devices, pharmaceutical products, and surgical instruments. 

Modern equipment is increasingly incorporating automated validation, digital monitoring, shorter processing cycles, and improved operational controls. These developments are helping healthcare organizations improve workflow efficiency while maintaining stringent sterilization standards.

The consumables segment is also gaining momentum. Grand View Research indicates that this segment is expected to grow at a 7.9% rate during the forecast period, supported by rising surgical procedures, greater use of sterilization indicators, and stricter infection-control requirements. 

Low-Temperature Sterilization Gains Importance

By method, low-temperature sterilization held the largest share in 2025 at 59.2%. Its strong position is closely associated with the growing use of heat- and moisture-sensitive medical devices. Technologies using ethylene oxide, hydrogen peroxide gas plasma, ozone, and vaporized peracetic acid allow delicate devices to be sterilized without exposure to the high temperatures associated with conventional steam processing. 

Low-temperature techniques are particularly valuable for minimally invasive surgical instruments, flexible endoscopes, implantable devices, and other complex equipment. The recognition of vaporized hydrogen peroxide as an established sterilization method by the U.S. FDA in January 2024 has further supported confidence in advanced low-temperature approaches.

At the same time, high-temperature steam sterilization continues to play an important role for heat- and moisture-resistant instruments. Steam sterilization generally operates between 121°C and 134°C, making it suitable for surgical tools, stainless-steel instruments, reusable glassware, and similar products. 

Hospitals Remain a Major End-use Segment

Hospitals are central to demand for terminal sterilization services because of the large volume of surgical instruments and medical devices that require validated sterilization. The hospitals segment accounted for 33.8% of revenue in 2025, making it the leading end-use category.

Increasing surgical activity, infection-control initiatives, and regulatory requirements are encouraging hospitals and clinics to strengthen sterilization protocols. Terminal sterilization helps healthcare organizations minimize contamination risks and support patient safety while complying with increasingly rigorous standards.

Ambulatory surgery centers are another important growth area. The expansion of outpatient procedures is increasing demand for efficient sterilization systems capable of processing surgical instruments within shorter operational cycles. Cataract procedures, orthopedic interventions, endoscopic procedures, and other outpatient surgeries are contributing to this trend. 

Rising Healthcare-Associated Infections Drive Demand

The increasing prevalence of healthcare-associated infections is one of the major factors supporting market expansion. According to information cited by Grand View Research, approximately 4.3 million hospitalized patients across the European Union and European Economic Area are affected by HAIs annually. In the U.S., a January 2024 study estimated that approximately 1.7 million patients are affected by HAIs each year, with these infections associated with an estimated 99,000 deaths annually. 

These figures highlight the continuing importance of infection prevention. Hospitals and medical facilities are therefore investing in reliable sterilization processes to reduce contamination risks associated with surgical instruments and other reusable or sterile products.

Regulatory agencies are also reinforcing the importance of validated sterilization. The FDA, European Medicines Agency, and World Health Organization emphasize appropriate sterility assurance for medical devices, surgical instruments, and sterile pharmaceutical products. The FDA's 2024 guidance further strengthened attention toward established and emerging sterilization technologies. 

Looking for more specific insights? Customize this report to suite your business needs

Regional Market Insights

North America held the largest regional revenue share, accounting for 33.8% in 2025. Strong healthcare infrastructure, regulatory oversight, high surgical volumes, an aging population, and growing demand for advanced medical technologies are supporting the region's leadership. The U.S. represented 88.8% of the North American market in 2025. 

Asia Pacific is emerging as an important growth region. Expansion of healthcare infrastructure, increasing medical device production, rising surgical volumes, and growing adoption of outsourced sterilization services are creating opportunities across China, India, Japan, Australia, and other countries. Medical device and pharmaceutical manufacturers are increasingly turning toward specialized sterilization providers to improve efficiency and meet regulatory requirements. 

Europe is also supported by stringent medical device regulations, an aging population, increasing chronic diseases, and greater attention to infection prevention. Meanwhile, Latin America and the Middle East & Africa are witnessing growing investment in healthcare infrastructure and sterile processing capabilities.

Major Growth Opportunities and Challenges

The increasing outsourcing of sterilization activities represents a major opportunity. Establishing and maintaining advanced sterilization infrastructure requires substantial investment, specialized expertise, validation, monitoring, and regulatory compliance. Outsourcing allows manufacturers and healthcare organizations to access specialized capabilities without carrying the entire operational burden internally.

The growing adoption of biologics, single-use components, minimally invasive devices, and sophisticated surgical instruments is also creating demand for specialized sterilization technologies.

However, environmental and regulatory concerns remain challenges, particularly for technologies involving ethylene oxide. Sterilization providers are therefore exploring cleaner technologies, including hydrogen peroxide, radiation, and other advanced approaches. The industry is simultaneously investing in automation and energy-efficient systems to improve sustainability.

Competitive Landscape

The terminal sterilization services industry is moderately fragmented, with established global companies and regional participants competing through technology development, service expansion, geographic growth, and strategic partnerships. 

Key companies identified by Grand View Research include:

• ASP (Fortive)

• Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.)

• DE LAMA S.P.A.

• Genist Technocracy Pvt. Ltd.

• Getinge

• Andersen Sterilizers

• Labotronics Scientific

• Labtron Equipment Ltd

• STERIS

• Stryker

• Qingdao Antech Scientific Co., Ltd.

• MATACHANA

• Solventum

• Steelco S.p.A.

• RENOSEM CO., LTD.

• Tuttnauer 

Companies are increasingly focused on advanced low-temperature technologies, automation, sterilization monitoring, and environmentally responsible processes. Product introductions and acquisitions are also helping major participants expand their technology portfolios and geographic presence.